Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries

We are analyzing https://link.springer.com/article/10.1186/s13578-019-0362-3.

Title:
TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts | Cell & Bioscience
Description:
Myofibroblasts are non-muscle contractile cells that play a key physiologically role in organs such as the stem villi of the human placenta during physiological pregnancy. They are able to contract and relax in response to changes in the volume of the intervillous chamber. Myofibroblasts have also been observed in several diseases and are involved in wound healing and the fibrotic processes affecting several organs, such as the liver, lungs, kidneys and heart. During the fibrotic process, tissue retraction rather than contraction is correlated with collagen synthesis in the extracellular matrix, leading to irreversible fibrosis and, finally, apoptosis of myofibroblasts. The molecular motor of myofibroblasts is the non-muscle type IIA and B myosin (NMMIIA and NMMIIB). Fibroblast differentiation into myofibroblasts is largely governed by the transforming growth factor-β1 (TGF-β1). This system controls the canonical WNT/β-catenin pathway in a positive manner, and PPARγ in a negative manner. The WNT/β-catenin pathway promotes fibrosis, while PPARγ prevents it. This review focuses on the contractile properties of myofibroblasts and the conductor, TGF-β1, which together control the opposing interplay between PPARγ and the canonical WNT/β-catenin pathway.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

pubmed, article, google, scholar, cas, pparγ, tgfβ, fibrosis, myofibroblasts, cells, central, signaling, pathway, canonical, wnt, cell, differentiation, human, smad, contractile, tissue, activation, role, vallée, myofibroblast, fibroblasts, fibrotic, wntβcatenin, expression, growth, peroxisome, receptor, biol, proliferatoractivated, observed, process, muscle, lecarpentier, wound, kinase, physiol, stem, ligands, myosin, factor, complex, gamma, taz, collagen, protein,

Topics {✒️}

peroxisome proliferator-activated receptor-alpha peroxisome proliferator-activated receptor-gamma peroxisome proliferator-activated receptor-γ tgf-β1-induced sapk/jnk signaling tgf-beta1-induced epithelial-mesenchymal transition tgf-β1/wnt/β-catenin pathway camkii-tak1-nlk-tab 2 inhibits canonical wnt/beta-catenin pathway peroxisome proliferator-activated receptor l-amino acid-defined diet canonical wnt/β-catenin pathway canonical wnt/-β-catenin pathway canonical wnt/β-catenin signaling transforming growth factor-beta transforming growth factor-beta1 prevent tgf-β1-induced fibrosis serine/threonine protein kinase transforming growth factor-β1 glycogen synthase kinase-3β peroxisome proliferator-activated receptors tgf-beta1-induced myofibroblast differentiation prevent β-catenin degradation tgf-β-induced pi3k/akt atp-adp-pi actin-myosin interaction beta-catenin/lef-1 pathway platelet-derived growth factor nf-e2-related factor 2 canonical wnt/β-catenin il-6 nf-kappab induced low-density lipoprotein receptor wnt/β-catenin pathway smad-independent tgf-β1 signaling article download pdf myocyte β1-adrenergic receptor wnt/β-catenin signaling wnt/beta-catenin pathways alpha-smooth muscle actin g-protein coupled receptor tgf-β induced collagen pparγ-induced tensin homologue β-catenin destruction complex bleomycin-induced pulmonary fibrosis gsk-3β activity leads cadherin-mediated cell adhesion β-catenin-dependent manner collagen-induced profibrotic signal tgf-β1 tgf-β αvβ6 stimulate tgf-β1 β-catenin target genes tgf-β-mediated fibrosis

Questions {❓}

  • Canonical Wnt signalling as a key regulator of fibrogenesis—implications for targeted therapies?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts
         description:Myofibroblasts are non-muscle contractile cells that play a key physiologically role in organs such as the stem villi of the human placenta during physiological pregnancy. They are able to contract and relax in response to changes in the volume of the intervillous chamber. Myofibroblasts have also been observed in several diseases and are involved in wound healing and the fibrotic processes affecting several organs, such as the liver, lungs, kidneys and heart. During the fibrotic process, tissue retraction rather than contraction is correlated with collagen synthesis in the extracellular matrix, leading to irreversible fibrosis and, finally, apoptosis of myofibroblasts. The molecular motor of myofibroblasts is the non-muscle type IIA and B myosin (NMMIIA and NMMIIB). Fibroblast differentiation into myofibroblasts is largely governed by the transforming growth factor-β1 (TGF-β1). This system controls the canonical WNT/β-catenin pathway in a positive manner, and PPARγ in a negative manner. The WNT/β-catenin pathway promotes fibrosis, while PPARγ prevents it. This review focuses on the contractile properties of myofibroblasts and the conductor, TGF-β1, which together control the opposing interplay between PPARγ and the canonical WNT/β-catenin pathway.
         datePublished:2019-12-09T00:00:00Z
         dateModified:2019-12-09T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1186/s13578-019-0362-3
         keywords:
            Transforming growth factor-β1
            PPARγ
            Canonical WNT/-β-catenin
            YAP/TAZ
            Smad
            Myofibroblasts
            Fibrosis
            Myosin
            Cell Biology
            Microbiology
            Stem Cells
            Neurobiology
            Proteomics
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-019-0362-3/MediaObjects/13578_2019_362_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-019-0362-3/MediaObjects/13578_2019_362_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-019-0362-3/MediaObjects/13578_2019_362_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-019-0362-3/MediaObjects/13578_2019_362_Fig4_HTML.png
         isPartOf:
            name:Cell & Bioscience
            issn:
               2045-3701
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Alexandre Vallée
               affiliation:
                     name:Hôpital Foch
                     address:
                        name:Délégation à la Recherche Clinique (DRCI), Hôpital Foch, Suresnes, France
                        type:PostalAddress
                     type:Organization
                     name:Université de Poitiers, CHU de Poitiers
                     address:
                        name:DACTIM-MIS, Laboratoire de Mathématiques et Applications (LMA), CNRS, UMR 7348, Université de Poitiers, CHU de Poitiers, Poitiers, France
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Yves Lecarpentier
               affiliation:
                     name:Grand Hôpital de l’Est Francilien (GHEF)
                     address:
                        name:Centre de Recherche Clinique, Grand Hôpital de l’Est Francilien (GHEF), Meaux, France
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts
      description:Myofibroblasts are non-muscle contractile cells that play a key physiologically role in organs such as the stem villi of the human placenta during physiological pregnancy. They are able to contract and relax in response to changes in the volume of the intervillous chamber. Myofibroblasts have also been observed in several diseases and are involved in wound healing and the fibrotic processes affecting several organs, such as the liver, lungs, kidneys and heart. During the fibrotic process, tissue retraction rather than contraction is correlated with collagen synthesis in the extracellular matrix, leading to irreversible fibrosis and, finally, apoptosis of myofibroblasts. The molecular motor of myofibroblasts is the non-muscle type IIA and B myosin (NMMIIA and NMMIIB). Fibroblast differentiation into myofibroblasts is largely governed by the transforming growth factor-β1 (TGF-β1). This system controls the canonical WNT/β-catenin pathway in a positive manner, and PPARγ in a negative manner. The WNT/β-catenin pathway promotes fibrosis, while PPARγ prevents it. This review focuses on the contractile properties of myofibroblasts and the conductor, TGF-β1, which together control the opposing interplay between PPARγ and the canonical WNT/β-catenin pathway.
      datePublished:2019-12-09T00:00:00Z
      dateModified:2019-12-09T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1186/s13578-019-0362-3
      keywords:
         Transforming growth factor-β1
         PPARγ
         Canonical WNT/-β-catenin
         YAP/TAZ
         Smad
         Myofibroblasts
         Fibrosis
         Myosin
         Cell Biology
         Microbiology
         Stem Cells
         Neurobiology
         Proteomics
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-019-0362-3/MediaObjects/13578_2019_362_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-019-0362-3/MediaObjects/13578_2019_362_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-019-0362-3/MediaObjects/13578_2019_362_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13578-019-0362-3/MediaObjects/13578_2019_362_Fig4_HTML.png
      isPartOf:
         name:Cell & Bioscience
         issn:
            2045-3701
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Alexandre Vallée
            affiliation:
                  name:Hôpital Foch
                  address:
                     name:Délégation à la Recherche Clinique (DRCI), Hôpital Foch, Suresnes, France
                     type:PostalAddress
                  type:Organization
                  name:Université de Poitiers, CHU de Poitiers
                  address:
                     name:DACTIM-MIS, Laboratoire de Mathématiques et Applications (LMA), CNRS, UMR 7348, Université de Poitiers, CHU de Poitiers, Poitiers, France
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Yves Lecarpentier
            affiliation:
                  name:Grand Hôpital de l’Est Francilien (GHEF)
                  address:
                     name:Centre de Recherche Clinique, Grand Hôpital de l’Est Francilien (GHEF), Meaux, France
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell & Bioscience
      issn:
         2045-3701
      volumeNumber:9
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Hôpital Foch
      address:
         name:Délégation à la Recherche Clinique (DRCI), Hôpital Foch, Suresnes, France
         type:PostalAddress
      name:Université de Poitiers, CHU de Poitiers
      address:
         name:DACTIM-MIS, Laboratoire de Mathématiques et Applications (LMA), CNRS, UMR 7348, Université de Poitiers, CHU de Poitiers, Poitiers, France
         type:PostalAddress
      name:Grand Hôpital de l’Est Francilien (GHEF)
      address:
         name:Centre de Recherche Clinique, Grand Hôpital de l’Est Francilien (GHEF), Meaux, France
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Alexandre Vallée
      affiliation:
            name:Hôpital Foch
            address:
               name:Délégation à la Recherche Clinique (DRCI), Hôpital Foch, Suresnes, France
               type:PostalAddress
            type:Organization
            name:Université de Poitiers, CHU de Poitiers
            address:
               name:DACTIM-MIS, Laboratoire de Mathématiques et Applications (LMA), CNRS, UMR 7348, Université de Poitiers, CHU de Poitiers, Poitiers, France
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Yves Lecarpentier
      affiliation:
            name:Grand Hôpital de l’Est Francilien (GHEF)
            address:
               name:Centre de Recherche Clinique, Grand Hôpital de l’Est Francilien (GHEF), Meaux, France
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Délégation à la Recherche Clinique (DRCI), Hôpital Foch, Suresnes, France
      name:DACTIM-MIS, Laboratoire de Mathématiques et Applications (LMA), CNRS, UMR 7348, Université de Poitiers, CHU de Poitiers, Poitiers, France
      name:Centre de Recherche Clinique, Grand Hôpital de l’Est Francilien (GHEF), Meaux, France

External Links {🔗}(549)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

5.41s.